IC
ENZN

Icahn Carl’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Icahn Carl’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,904,863
Closed -$2.77M – 22
2016
Q1 		$2.77M Hold
5,904,863
– – 0.01% 20
2015
Q4 		$4.03M Hold
5,904,863
– – 0.01% 26
2015
Q3 		$5.73M Hold
5,904,863
– – 0.02% 24
2015
Q2 		$7.09M Hold
5,904,863
– – 0.02% 22
2015
Q1 		$6.26M Hold
5,904,863
– – 0.02% 20
2014
Q4 		$6.44M Hold
5,904,863
– – 0.02% 21
2014
Q3 		$6.38M Hold
5,904,863
– – 0.02% 20
2014
Q2 		$6.14M Hold
5,904,863
– – 0.02% 18
2014
Q1 		$6.08M Hold
5,904,863
– – 0.02% 18
2013
Q4 		$6.85M Hold
5,904,863
– – 0.02% 17
2013
Q3 		$9.92M Hold
5,904,863
– – 0.04% 17
2013
Q2 		$11.8M Buy
+5,904,863
New +$17.3M 0.05% 18

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Icahn Carl's ENZN Position: Q2 2016 in Review

Icahn Carl sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 5,904,863 shares — an estimated $2.77M sold.

Icahn Carl first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $11.8M in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Icahn Carl reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Icahn Carl sold 5,904,863 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $2.77M.
  • Icahn Carl first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Icahn Carl's ENZON PHARMACEUTICALS INC position peaked at $11.8M in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Icahn Carl's 13F filing for Q2 2016, filed 15 Aug 2016.